SLAS (Society for Laboratory Automation and Screening) · 3 hours ago
Principal Research Scientist I or Senior Scientist II, Biologics Analytical Research and Development, CMC Biologics Development
North Chicago, IL
Full-time
Onsite
Senior Level
4+ years expAbbVie is a global biopharmaceutical company dedicated to discovering and delivering innovative medicines for serious health issues. The role involves leading analytical development strategies for biologics characterization and contributing to the advancement of AbbVie's pipeline through scientific collaboration and technical oversight.
AssociationBiotechnologyCommunitiesGovernmentInformation Technology
Responsibilities
Serve as a subject matter expert in BioARD, lead phase-appropriate analytical development strategies for biologics characterization including ADC, multi-specific antibodies, and other novel modalities
Design and execute the buildout of chromatography and/or mass spectrometry methods for extended characterization, product release, stability, comparability, and in-process analytics
Make lab-based, data-driven contributions to project team and deliver results in a team-oriented setting and will work across scientific disciplines to drive programs through critical milestones
Represent key area function in cross-functional project teams, provide hands-on analytical support, technical oversight to portfolios
Collaborate and integrate scientific objectives associated with development of new/improved products or technology; contribute to internal scientific exchange and publications
Author, review lab notebook, analytical report, and analytical sections of regulatory filings. Primary author of external publications, presentations, regulatory documents and/or primary inventor of patents. Present at leading scientific conferences
May mentor/supervise a team of one or more, guide and evaluate the performance of those individuals; is accountable for the effective performance of the team/individuals
Qualification
Required
PhD in scientific discipline (e.g., Analytical Chemistry, Biochemistry, or Biology) with 6+ years of industry experience
Proficiency and direct experience in large biologics characterization and separation techniques, including various chromatography analytical methods (SEC/HIC/RPLC/IEC), intact or subunit mass analysis, peptide mapping
Knowledge in key analytical CMC areas, such as risk-based analytical development and method validation, CQAs, reference standard qualification, specifications, comparability
Familiarity with biologics CE, icIEF, biophysical assays, or binding and functional assays are plus
Working knowledge of lab automation, good written and oral communication skills, time management skills
Ability to work independently and collaboratively across functions
PhD in scientific discipline (e.g., Analytical Chemistry, Biochemistry, or Biology) with 4+ years of industry experience OR
Master's degree in related fields with 8-10+ years of industry experience
Proficiency and direct experience in large biologics characterization and separation techniques, including various chromatography analytical methods (SEC/HIC/RPLC/IEC), intact or subunit mass analysis, peptide mapping
Knowledge in key analytical CMC areas, such as risk-based analytical development and method validation, CQAs, reference standard qualification, specifications, comparability
Familiarity with biologics CE, icIEF, biophysical assays, or binding and functional assays are plus
Working knowledge of lab automation, good written and oral communication skills, time management skills
Ability to work independently and collaboratively across functions
Benefits
Paid time off (vacation, holidays, sick)
Medical/dental/vision insurance
401(k)
Company
SLAS (Society for Laboratory Automation and Screening)
SLAS, headquartered in Oak Brook, IL, is a tax exempt organization under section 501 (c) (3) of the United States Internal Revenue Code.
11-50 employees
Funding
Current Stage
Early StageLeadership Team
Vicki Loise
CEO
Amy Wilkinson
Director, Global Events and Corporate Partnerships
Recent News
2026-02-02
2025-10-23
Company data provided by crunchbase